Rifampicin was discovered in 1965 and remains one of the most important drugs in
tuberculosis treatment that is valued for its sterilizing activity and ability to shorten treatment …

Tuberculosis is a global health challenge due to its spreading potential. The Kingdom of
Saudi Arabia (KSA) faces a challenge in the spread of tuberculosis from migrant workers …

India accounts for about one-fourth of the global burden of MDR-TB. This study aims to
assess the prevalence and factors associated with tuberculosis drug resistance among …

Background Tuberculosis (TB) is among the top 10 causes of mortality and the first killer
among infectious diseases worldwide. One of the factors fuelling the TB epidemic is the …

Background The emergence of drug resistance is a threat to global tuberculosis (TB)
elimination goals. This study investigated the drug resistance profiles of Mycobacterium …

Objectives Tuberculosis (TB) is a preventable and treatable infectious disease, but the
continuing emergence and spread of multidrug-resistant TB is threatening global TB control …

GeneXpert MTB/RIF is a rapid molecular diagnostic tool capable of simultaneously detecting
Mycobacterium tuberculosis and rifampicin resistance. This study aimed to assess the …

The emergence and transmission of multidrug resistant (MDR) and extensively drug
resistant (XDR) Mycobacterium tuberculosis (M. tb) strains is a threat to global tuberculosis …

Background: India is one of the top most country among the high tuberculosis (TB) burden
countries and ranks the third highest human immunodeficiency virus (HIV) burden country in …

Background: Tuberculosis is one of the top 10 causes of death worldwide as per the Global
TB report 2017, the estimated incidence of TB in India was approximately 28, 00,000 cases …